Drug-induced gingival overgrowth and its tentative pharmacotherapy

Japanese Dental Science Review - Tập 46 - Trang 11-16 - 2010
Hiroko Matsumoto1,2, Reiri Takeuchi1, Makiko Ono3, Yoshiaki Akimoto2,3, Naomi Kobayashi4, Akira Fujii4,5
1Department of Oral Molecular Pharmacology, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba 271-8587, Japan
2Research Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba 271-8587, Japan
3Department of Oral Surgery, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba 271-8587, Japan
4Department of Clinical Pharmacology, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba 271-8587, Japan
5Research Institute of Oral Science, University Research Center, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba 271-8587, Japan

Tài liệu tham khảo

Ramon, 1984, Gingival hyperplasia caused by nifedipine—a preliminary report, Int J Cardiol, 5, 195, 10.1016/0167-5273(84)90145-1 Lederman, 1984, Gingival hyperplasia associated with nifedipine therapy. Report of a case, Oral Surg Oral Med Oral Pathol, 57, 620, 10.1016/0030-4220(84)90283-4 Katsumi, 1991, Statistical study of incidence of gingival hyperplasia induced by hypotensive drugs (Ca channel blockers), J Jpn Stomatol Soc, 40, 169 Ono, 2008, Incidence of gingival overgrowth caused by calcium channel blockers, Oral Ther Pharmacol, 27, 79 Seymour, 1991, Calcium channel blockers and gingival overgrowth, Br Dent J, 170, 376, 10.1038/sj.bdj.4807564 Akimoto, 1997, Incidence of gingival overgrowth induced by calcium channel blockers, Jpn J Clin Pharmacol Ther, 28, 481, 10.3999/jscpt.28.481 Barak, 1987, Gingival hyperplasia caused by nifedipine. Histopathologic findings, J Periodontol, 58, 639, 10.1902/jop.1987.58.9.639 Barclay, 1992, The incidence and severity of nifedipine-induced gingival overgrowth, J Clin Periodontol, 19, 311, 10.1111/j.1600-051X.1992.tb00650.x Fujii, 1994, Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders, Arch Oral Biol, 39, 99, 10.1016/0003-9969(94)90103-1 Matsumoto, 2001, Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders, J Oral Sci, 43, 261, 10.2334/josnusd.43.261 Sato, 2005, The effect of IL-1α and nifedipine of cell proliferation and DNA synthesis in cultured human gingival fibroblasts, J Oral Sci, 47, 105, 10.2334/josnusd.47.105 Sato, 2008, Effects of interleukin-1α on the production and release of basic fibroblast growth factor in cultured nifedipine-reactive gingival fibroblasts, J Oral Sci, 50, 83, 10.2334/josnusd.50.83 Byron, 1992, Bradykinin-induced Ca2+ entry, release, and refilling of intracellular Ca2+ stores. Relationships revealed by image analysis of individual human fibroblasts, J Biol Chem, 267, 108, 10.1016/S0021-9258(18)48466-9 Berridge, 1993, Inositol trisphosphate and calcium signalling, Nature, 361, 315, 10.1038/361315a0 Fujii, 1995, Effect of bradykinin on cytosolic calcium response in cultured gingival fibroblasts derived from nifedipine responders and non-responders, Cellular Pharmacol, 2, 171 Takeuchi, 2004, The effect of basic fibroblast growth factor on cell cycle in human gingival fibroblasts from nifedipine responder and non-responder, J Oral Sci, 46, 37, 10.2334/josnusd.46.37 Hori, 2008, The effect of insulin-like growth factor-I on cell cycle in human gingival fibroblasts from nifedipine responders and non-responders, Oral Ther Pharmacol, 27, 25 Takeuchi, 2007, Differences of cell growth and cell cycle regulators induced by basic fibroblast growth factor between nifedipine responders and non-responders, J Pharmacol Sci, 103, 168, 10.1254/jphs.FP0060928 Noji, 2002, p38 MAPK activation in cultured gingival fibroblasts from nifedipine responder and non-responder, Nihon Univ J Oral Sci, 28, 102 Takeuchi, 2008, Relationship between gingival overgrowth and lipopolysaccharide induced apoptosis Hashimoto, 1997, Nifedipine increases diacylglycerol level and protein kinase C activity in human gingival fibroblasts, Nihon Univ J Oral Sci, 23, 117 Gunji, 2008, Relationship between cAMP level and intracellular Ca2+ response elicited by histamine in human gingival fibroblasts, Oral Ther Pharmacol, 27, 45 Conklyn, 1990, Inhibition of IgE-mediated N-acetylglucosaminidase and serotonin release from rat basophilic leukemia cells (RBL-2H3) by tenidap: a novel anti-inflammatory agent, Int Arch Allergy Appl Immunol, 91, 369, 10.1159/000235143 Blackburn, 1991, Tenidap, in contrast to several available nonsteroidal antiinflammatory drugs, potently inhibits the release of activated neutrophil collagenase, Arthritis Rheum, 34, 211, 10.1002/art.1780340213 Moilanen, 1988, CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro, Eicosanoids, 1, 35 Blackburn, 1991, Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis, Arthritis Rheum, 34, 204, 10.1002/art.1780340212 Sipe, 1992, Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response, J Immunol, 148, 480, 10.4049/jimmunol.148.2.480 Cleveland, 1993, Fewtrell CMS. Tenidap: a novel inhibitor of calcium influx in a mast cell line, Cell Calcium, 14, 1, 10.1016/0143-4160(93)90013-V Fujii, 1995, Tenidap an anti-inflammatory agent, discharges intracellular Ca++ store and inhibits Ca++ influx in cultured human gingival fibroblasts, J Pharmacol Exp Ther, 275, 1447 Matsumoto, 2002, Tenidap, an anti-inflammatory agent, inhibits DNA and collagen syntheses, depresses cell proliferation, and lowers intracellular pH in cultured human gingival fibroblasts, J Pharmacol Exp Ther, 300, 668, 10.1124/jpet.300.2.668 Hakozaki, 2008, Effect of tenidap on MMP-1 formation in nifedipine-reactive human gingival fibroblasts, Oral Ther Pharmacol, 27, 53 Matsumoto, 1995, Tenidap may depress gingival hyperplasia caused by nifedipine Fujii, 1997, Tenidap may depresses experimental gingival overgrowth caused by nifedipine in rats and dogs Wang, 1991, Inhibition of mutagenicity in Salmonella typhimurium and skin tumor initiating and tumor promoting activities in SENCAR mice by glycyrrhetinic acid: comparison of 18α- and 18β-stereoisomers, Carcinogenesis, 12, 187, 10.1093/carcin/12.2.187 Kimura, 2001, Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors, Eur J Pharmacol, 431, 151, 10.1016/S0014-2999(01)01424-8 Rossi, 2003, Selectivity of action of glycyrrhizin derivatives on the growth of MCF-7 and HEP-2 cells, Anticancer Res, 23, 3813 Rossi, 1995, Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumor cells, In Vivo, 9, 183 Matsui, 2004, Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line, Int Immunopharmacol, 4, 1633, 10.1016/j.intimp.2004.07.023 Amagaya, 1984, Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities, J Pharm Dyn, 7, 923, 10.1248/bpb1978.7.923 Okada, 2007, Effect of 18α-glycyrrhetinic acid on the growth of nifedipine responder cell, Oral Ther Pharmacol, 26, 1 Heijl, 1988, Nitrendipine-induced gingival overgrowth in dogs, J Periodontol, 60, 104, 10.1902/jop.1989.60.2.104 Takeuchi, 2009, 18α-Glycyrrhetinic acid induces the apoptosis in gingival fibroblast derived from gingival overgrowth patient by nifedipine, Oral Ther Pharmacol, 28, 65